PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Use of Prostaglandin E1 (EDEX) in the therapy of erectile dysfunction.
Article published in Urologia Polska 1996/49/2.

authors

Barbara Darewicz, Tadeusz Werel, Janusz Darewicz, Eugeniusz Malczyk
Z Kliniki Urologu Akademii Medycznej w Białymstoku.
Kierownik Kliniki: Prof. dr hab.med. Janusz Darewicz.

keywords

impotence pharmacological treatment prostaglandine PGE1

summary

To provoke an erection after an ijeetion of prostaglandine Ej (PGEj) into cavernous
body in impotent patients.
26 impontent patients, 10 with psychogenic and 16 witch organic impotence were
treated with PGEj. To provoke the erection 20 micrograms of PGEj in lml 0,9% saline
were injected into cavemous body.
After 3 to 5 minutes from the injection appeared an erection lasting 30 to 90 minutes.
All 10 patients with psychogenic and 12 out of 16 with organic impotence had good
erection. There were no adverse side effects during the management.
The injection of prostaglandine PGA1 into cavernous body is a successful method of
management in any cause of impotence.

references

  1. 1. Andersson K. E., Holmquist E, Wagner G.: Pharmacology of drugs used for treat-
  2. ment of erectile dysfunction and priapism. Int. J. Impotence Res., 1991, 3, 2, 155.
  3. 2. Bńndley G. S.: Cavernosal alpha-blockade: a new techniąue for investigating and
  4. treating erectile impotence. Brit. J. Psychiat., 1983, 143, 3, 332.
  5. 3. Gałek L., Darewicz J., Darewicz B., Kudelski J.: Diagnostyczna wartość prostaglan-
  6. dyny E, w porównaniu z testem papawerynowym w diagnostyce impotencji. Urol.
  7. Pol., 1995, 48, 2,140.
  8. 4. Golub M., Zia R, Matsuno M., Horton R. : Metabolism ofprostaglandins A1 and E1 in
  9. man. J. Clin. Invest., 1975, 59, 6, 1404.
  10. 5. Hedlung II., Anderson K.E.: Contraction and relaxation induced by some prostano-
  11. ids in isolated human penile erectile tissue and cavernous artery. J. Urol., 1985, 134,
  12. 5, 1245.
  13. 6. Ishii N., Watanabe II., Irisawa C, Kikuchi, Kawamura S., Suzuki K., Chiba R, Tolki-
  14. wa M., Sbirai M.: Studies on male sexual impotence. Report 18. Therapeutic trial
  15. with Prostaglandin A1 for organic impotence. Jap. J. Urol., 1986, 77, 5, 954.
  16. 7. Junemann K. R, Alken R: Phifrmacotherapy of erectile dysfunction: a review. Int. J.
  17. Impotence Res., 1989, 1, 2, 71.
  18. 8. Prost II., Van Ahlen II., Block T., Halbig W.: Intracavernous self-injection of prosta-
  19. glandin A1 in the therapy of erectile dysfunction. VASA-Suppl.,1989, 28.
  20. 9. Reiss II.: Use of Prostaglandin A1 for papaverine - failed ereetions. Urology, 1989,
  21. 33,1,15.
  22. 10. Stackl W,: Hasun R., Marberger M.: Intracavernous injection of Prostaglandin A1 in
  23. impotent men. J. Urol., 1988, 140, 1, 66.
  24. 11. Virag R: Intracavernous injection of papaverine for erectile failure. Lancet,1982, 2,
  25. 4, 938.
  26. 12. Virug R., Frydman /)., Legman M, Virag II. : Intracavemous injection of papaverine
  27. as a diagnostic and therapeutic method in erectile failure. Angiology, 1984, 35, 1, 79.
  28. 13. Zorgniolti A. W., Lejleur R. S.: Auto-injection of the corpus cavemosum with a vaso-
  29. active drug Combination for vasculogenic impotence. J. Urol.,1985,133, 1, 39,